Table 1 Baseline characteristics.

From: Altered pupillary light responses are associated with the severity of autonomic symptoms in patients with Fabry disease

 

Controls (n = 14)

Fabry disease (n = 14)

Age (years, median [IQR])

30.5 [26.8–40.5]

30.0 [27.3–42.0]

Sex (F/M)

6/8

6/8

α-Galactosidase A enzyme activity (µmol/L/h)

–

1.41 ± 0.78

Duration of ERT (months)

–

24.2 ± 10.8

MSSI

–

20.7 ± 8.7

COMPASS 31 Total weighted score

–

28.5 ± 14.5

COMPASS 31 Pupillomotor weighted sub-score

–

2.2 ± 0.9

  1. Data are expressed as mean ± SD for parametric variables and median [IQR] for non-parametric variables.
  2. COMPASS Composite Autonomic Symptom Scale, ERT enzyme replacement therapy, MSSI Mainz Severity Score Index.
Back to article page